Veeco Secures DOE Grant to Commercialize CIGS Solar Cell Technology

Veeco Instruments, manufacturer of solar panel solutions, has been awarded a U.S. Department of Energy (DOE) funding to quicken the research and development for commercializing the Copper, Indium, Gallium, Selenium (CIGS) deposition systems.

The $4.8 million grant will enable the company to accelerate the commercialization procedure of multi-stage thermal deposition solutions for producing CIGS Solar cells.

DOE’s grant was a part of the SunShot High-Impact Supply Chain R&D Program, which aims to attain equal pricing between fossil-based electricity and solar electricity without utilizing additional subsidies.

Senator Kirsten Gillibrand stated that the $4.8 million grant would help in enhancing the research and development of solar power technology, thereby making solar power more efficient. He added that by making solar power more efficient, emissions can be reduced, thereby improving our environment.

Source: http://www.veeco.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Veeco. (2019, February 28). Veeco Secures DOE Grant to Commercialize CIGS Solar Cell Technology. AZoOptics. Retrieved on April 23, 2024 from https://www.azooptics.com/News.aspx?newsID=13130.

  • MLA

    Veeco. "Veeco Secures DOE Grant to Commercialize CIGS Solar Cell Technology". AZoOptics. 23 April 2024. <https://www.azooptics.com/News.aspx?newsID=13130>.

  • Chicago

    Veeco. "Veeco Secures DOE Grant to Commercialize CIGS Solar Cell Technology". AZoOptics. https://www.azooptics.com/News.aspx?newsID=13130. (accessed April 23, 2024).

  • Harvard

    Veeco. 2019. Veeco Secures DOE Grant to Commercialize CIGS Solar Cell Technology. AZoOptics, viewed 23 April 2024, https://www.azooptics.com/News.aspx?newsID=13130.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.